Analysts expect RTI Surgical, Inc. (NASDAQ:RTIX) to announce sales of $69.95 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for RTI Surgical’s earnings. The highest sales estimate is $70.40 million and the lowest is $69.49 million. RTI Surgical posted sales of $71.35 million during the same quarter last year, which would indicate a negative year over year growth rate of 2%. The firm is scheduled to issue its next earnings results on Thursday, February 22nd.

On average, analysts expect that RTI Surgical will report full year sales of $69.95 million for the current financial year, with estimates ranging from $277.80 million to $278.75 million. For the next year, analysts expect that the company will report sales of $282.01 million per share, with estimates ranging from $281.68 million to $282.33 million. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting the consensus estimate of $0.01. The business had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. RTI Surgical had a net margin of 1.01% and a return on equity of 2.35%. The business’s revenue was up .2% compared to the same quarter last year.

Several research firms recently weighed in on RTIX. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, October 13th. BidaskClub downgraded shares of RTI Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, August 8th.

In other RTI Surgical news, Director Nicholas J. Valeriani purchased 5,500 shares of the business’s stock in a transaction on Monday, August 21st. The stock was bought at an average cost of $4.70 per share, with a total value of $25,850.00. Following the acquisition, the director now owns 47,754 shares of the company’s stock, valued at $224,443.80. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John N. Varela purchased 12,000 shares of the business’s stock in a transaction on Friday, August 11th. The stock was acquired at an average cost of $4.85 per share, with a total value of $58,200.00. Following the completion of the acquisition, the executive vice president now directly owns 47,998 shares in the company, valued at approximately $232,790.30. The disclosure for this purchase can be found here. 4.90% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Goldman Sachs Group Inc. lifted its holdings in RTI Surgical by 2.1% in the 2nd quarter. Goldman Sachs Group Inc. now owns 87,767 shares of the medical equipment provider’s stock valued at $513,000 after acquiring an additional 1,782 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in RTI Surgical by 1.1% in the 2nd quarter. Victory Capital Management Inc. now owns 220,569 shares of the medical equipment provider’s stock valued at $1,290,000 after acquiring an additional 2,295 shares during the last quarter. American International Group Inc. lifted its holdings in RTI Surgical by 7.0% in the 1st quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock valued at $141,000 after acquiring an additional 2,327 shares during the last quarter. Bank of America Corp DE lifted its holdings in RTI Surgical by 6.4% in the 1st quarter. Bank of America Corp DE now owns 39,786 shares of the medical equipment provider’s stock valued at $159,000 after acquiring an additional 2,389 shares during the last quarter. Finally, Voya Investment Management LLC raised its holdings in RTI Surgical by 12.1% during the 2nd quarter. Voya Investment Management LLC now owns 40,247 shares of the medical equipment provider’s stock worth $235,000 after buying an additional 4,356 shares during the period. 70.03% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “$69.95 Million in Sales Expected for RTI Surgical, Inc. (RTIX) This Quarter” was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2017/11/06/69-95-million-in-sales-expected-for-rti-surgical-inc-rtix-this-quarter.html.

Shares of RTI Surgical (RTIX) opened at $4.80 on Monday. The firm has a market cap of $285.64, a PE ratio of 120.00, a P/E/G ratio of 5.82 and a beta of 1.73. RTI Surgical has a 1-year low of $2.50 and a 1-year high of $6.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.00 and a quick ratio of 1.03.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.